Iris Acquisition Corp II Unbundles Units, Kicking Off Its Merger Hunt

DUBAI, United Arab Emirates – February 18, 2026 – Iris Acquisition Corp II, a special purpose acquisition company, announced today a key procedural step that signals its transition from post-IPO logistics to the active search for a business combination. The company confirmed that starting February 24, 2026, investors can separately trade its Class A ordinary shares and warrants.

The units, which were sold during the company's initial public offering and have been trading on the New York Stock Exchange under the ticker "IRAB U," will be unbundled. Following the split, the Class A ordinary shares will trade under the symbol "IRAB," and the warrants will trade as "IRAB WS." Investors who choose not to separate their holdings will see them continue to trade under the original "IRAB U" ticker.

This development is a standard and widely anticipated milestone in the lifecycle of a SPAC, typically occurring approximately 45 to 52 days after its IPO. For Iris Acquisition Corp II, it marks the formal end of its initial offering phase and turns the market's attention toward the management team's primary objective: identifying and merging with a private company to take it public.

What the Unit Split Means for Investors

For holders of Iris Acquisition Corp II units, the separation provides significantly greater flexibility and opens the door to new trading strategies. To initiate the split, investors must instruct their brokers, who will then coordinate with the company’s transfer agent, Odyssey Transfer & Trust Company.

The key benefit is liquidity. By unbundling the shares and warrants, investors can manage their exposure with more precision. An investor might choose to sell the Class A shares, which are redeemable for approximately their initial $10 value, while retaining the warrants. This popular strategy effectively creates a low-cost or "free" option on the future success of the SPAC. Warrants give the holder the right, but not the obligation, to purchase a share at a fixed price (typically $11.50) in the future, offering substantial upside if the company completes a successful merger that excites the market.

Conversely, more risk-averse investors might sell the warrants to lock in a small profit while holding the relatively stable shares, which are backed by the cash held in the SPAC's trust account. The company noted that no fractional warrants will be issued, meaning investors must hold enough units to create whole warrants upon separation.

This ability to trade components separately also attracts sophisticated investors who look for arbitrage opportunities. If the combined price of a separate share and warrant trades higher than the price of the intact unit, traders can profit from the difference by buying the units, splitting them, and immediately selling the components.

Navigating a Resurgent SPAC Market

Iris Acquisition Corp II's move comes amid a notable resurgence in the SPAC market. After a period of speculative frenzy in 2020-2021 followed by a sharp downturn, 2025 saw a significant rebound in SPAC IPOs. The market of 2026, however, is far more disciplined and professionalized.

Today's landscape is characterized by a "flight to quality," where investors favor SPACs led by experienced, serial sponsors with proven track records. Iris Acquisition Corp II's management team, which previously sponsored Iris Acquisition Corp. and successfully completed a business combination with Liminatus Pharma, Inc., fits this mold. This prior success may provide a degree of investor confidence in their ability to execute a deal.

Despite the market's renewed health, challenges remain. Redemption rates—the percentage of investors who choose to cash out their shares rather than participate in a merger—remain stubbornly high across the industry, often exceeding 95%. This trend forces SPAC sponsors to secure additional financing, known as a PIPE (private investment in public equity), to ensure their target company is adequately capitalized. It also underscores that many IPO investors still view SPACs as a short-term arbitrage trade rather than a long-term investment in the eventual target company.

Furthermore, increased regulatory scrutiny from the SEC has introduced new rules aimed at providing greater transparency and investor protection, holding sponsors to higher standards for financial projections and disclosures.

The Hunt for a Target Begins

With the unit separation underway, the focus shifts squarely to the "hunt." Led by CEO Sumit Mehta and Chairman Rohit Nanani, the Dubai-based management team has positioned Iris Acquisition Corp II as a "globally focused SPAC with a generalist investment approach."

While the company is officially sector-agnostic to maintain flexibility, its S-1 registration statement and the management's expertise provide significant clues about its likely areas of interest. The team has highlighted industries where it possesses deep domain knowledge and a global network, including:
* Technology, Media, and Telecommunications (TMT)
* Business and IT Services
* Consumer Products and Digital Brands
* Fintech and Crypto
* Education and EdTech
* Logistics and Mobility

The management team's global experience, with a track record of executing complex cross-border transactions across North America, the Middle East, Asia, and Europe, suggests a broad geographic canvas for their search. Their base in Dubai also positions them at a strategic crossroads of international capital and emerging market growth. The company has stated its goal is to find a high-quality, mid-market company that is poised for accelerated growth and can benefit from a public listing.

As the technical process of the unit separation completes, the clock is now ticking for the leadership of Iris Acquisition Corp II. They have a finite window, typically 18 to 24 months from their IPO, to identify a suitable partner and convince shareholders that the proposed deal will create long-term value in this new, more discerning market.